Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale Director sold 15,000 shares at $30.05 ($450,765)
  2. 4 Open-market sale EVP, DEVELOPMENT AND CMO sold 25,000 shares at $30.09 ($752,265)
  3. 4 Open-market sale CEO sold 30,000 shares at $29.28 ($878,397)
  4. 4 Open-market sale Director sold 5,810 shares at $29.00 ($168,490)
  5. 4 Open-market sale CEO sold 30,000 shares at $24.15 ($724,530)
  6. 4 Open-market sale Director sold 10,000 shares at $28.07 ($280,669)
  7. 4 Open-market sale Director sold 9,190 shares at $29.15 ($267,873)
  8. 4 Open-market sale CEO sold 30,000 shares at $27.36 ($820,821)
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Director sold 57,692 shares at $26.76 ($1,543,838)
  11. 4 Open-market sale Director sold 30,000 shares at an average $26.88 ($806,400)
  12. 4 Open-market sale CEO sold 15,000 shares at $22.89 ($343,371)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale CEO sold 20,000 shares at $22.22 ($444,374)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale CEO sold 20,000 shares at $23.10 ($462,004)
  17. 4 Open-market sale Director sold 15,000 shares at $23.03 ($345,456)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 21 of 35 · 686 filings